Please login to the form below
Cello Health Insight strengthens senior team
CEO, president and senior executives are hired
Cello Health Insight has appointed Kathryn Gallant (pictured right) as CEO in a role that will see her take on responsibility for the growth of Cello Health Insight focusing on building the US international revenue stream.
In addition to Gallant, Angie Wheeler (pictured left) has been appointed president to build on the US domestic market business.
Furthermore, Cello Health has hired Justine Trinidad, Ed Geiselhart and Kaity Arctander to support future growth and broaden the company’s offerings.
Jane Shirley, CEO at Cello Health Insight, said: “Kathryn and Angie have worked in partnership with great success for many years to build Cello Health Insight, US.
“This development in their roles combined with the new additions opens up further leadership opportunities for the team and truly supports our ability to drive growth and expand the business.”
Subscribe to our email news alerts
- No “White Space” Between Live Meetings; the top 10 benefits of virtual advisory boards
- Building trust with HCPs: 6 takeaways from our industry webinar
- Eli Lilly and PRISM BioLab enter drug discovery collaboration worth over $660m
- NHS to offer stem cell transplants to patients living with rare blood disorder
- First WHO Global Clinical Trial Forum develops joint vision to improve clinical research
- Merck shares positive phase 3 results for investigational pneumococcal vaccine in adults
No results were found
PMHub
Bedrock Healthcare Communications
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
